Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Edwards Lifesciences Corporation will participate in the J.P. Morgan Healthcare Conference on January 12, 2026, highlighting its commitment to innovation in the healthcare sector [1]. Company Participation - Bernard Zovighian, the CEO, is scheduled to present at 11:15 a.m. PT, indicating the company's leadership engagement in industry discussions [2]. - Scott Ullem, the CFO, will also participate, showcasing the company's financial strategy and insights [2]. - A live webcast of the presentation will be available on the investor relations website, with an archived version accessible later the same day, ensuring transparency and accessibility for investors [2]. Company Overview - Edwards Lifesciences is recognized as a leading global structural heart innovation company, focused on improving patient lives through advanced technologies [3]. - The company emphasizes a patient-focused culture, driven by partnerships with clinicians and healthcare stakeholders, to deliver life-changing innovations [3].